generic
PHARMACY

FDA approves Amerigen’s generic cyclophosphamide

BY David Salazar

The Food and Drug Administration has approved Amerigen Pharmaceuticals’ abbreviated new drug application for two dosage strengths of its cyclophosphamide capsules. The drug, a generic of West-Ward’s product, is an anti-neoplastic agent indicated to treat various cancers.

Amerigen’s generic cyclophosphamide will be available in 25- and 50-mg capsules. The company said it plans to launch the drug soon, manufactured by Irvine Pharmaceuticals.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer